Form 1-A POS WORTHY WEALTH, INC.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ProMIS Neurosciences Reports First Human Evidence of Amyloid-Beta Oligomer Target Engagement by PMN310 at AAIC 2026
- SATO Corporation Half-Year Report 1 January–30 June 2026: SATO’s steady development continued
- Dizal Announces Global Exclusive License Agreement with AstraZeneca for Zegfrovy
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share